Amanda Chaperot Ph.D Overview

  • Primary Position
  • Board Member

  • Primary Industry
  • B2C

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

Amanda Chaperot Ph.D General Information

Biography

Dr. Amanda Chaperot serves as Board Member at Vivet Therapeutics. She served as Partner, Life Sciences Team at Seventure Partners. She serves as a Board Member at CytoKi Pharma. She joined the Seventure Partners Life Sciences team in 2015. She brings international experience of more than 15 years in scientific and medical research, business development, and corporate venture. She began her career as an immunologist in academic research in Australia and then in Switzerland. She authored publications in Nature Immunology and was named Best New Researcher by the Australian Society for Immunology. After her first medical-marketing experience, she joined the Roche laboratory in Switzerland where she worked for nine years on external innovation in relation to start-ups developing innovative therapies and technologies all over the world. Her mission was to complete the Roche pipeline, first in business development and then in the corporate venture. An Australian, she holds a Ph.D. in Immunology and a Bachelor's Degree in Medical Science with First Class Honors from the University of Sydney. In addition, she obtained an MBA from IE Business School, Madrid.

Contact Information

Primary Position
Board Member, Vivet Therapeutics
Education
University of Sydney, Ph.D. (Doctor of Philosophy)
University of Lausanne, Degree
University of Sydney, Bachelor's
IE Business School, MBA (Master of Business Administration)
Gender
Female
Phone
+33 01
Address
  • 80 Boulevard Haussmann
  • 75008 Paris
  • France

Amanda Chaperot Ph.D Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Cytoki Drug Discovery Privately Held (backing) Venture Capital-Backed Søborg, Denmark
Vivet Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Paris, France

Amanda Chaperot Ph.D Lead Partner on Deals (1)

Amanda Chaperot Ph.D has been the lead partner on 1 deal. Their latest deal was with LARQ, a other consumer durables company. The deal was made for on 10-Jan-2020.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
LARQ 10-Jan-2020 Early Stage VC (Series A1) Completed Other Consumer Durables San Mateo, CA

Amanda Chaperot Ph.D Network (27)

Board Members (17)

Name Company Representing Location From
Beat Steffen MD Vivet Therapeutics Novartis Venture Fund Paris, France
Daniel Bach Ph.D Cytoki ND Capital Søborg, Denmark
Vivet Therapeutics Self Paris, France
Vivet Therapeutics Kurma Partners Paris, France
Vivet Therapeutics Roche Venture Fund Paris, France

Portfolio Executives (4)

Name Company Role Deal date Location
Robert Walker Ph.D LARQ Co-Founder & Board Member 10-Jan-2020 San Mateo, CA
Justin Wang LARQ Co-Founder, Chief Executive Officer, President & Board Member 10-Jan-2020 San Mateo, CA
LARQ Financial Controller 10-Jan-2020 San Mateo, CA
LARQ Co-Founder, Chief Technology Officer & Board Member 10-Jan-2020 San Mateo, CA

Fund Team Members (6)

Name Investor Fund Fund Location
Emmanuel Fiessinger Seventure Partners Digital Opportunities Fund Paris, France
David Manjarres Seventure Partners Digital Opportunities Fund Paris, France
Seventure Partners Paris, France
Seventure Partners Paris, France
Seventure Partners Paris, France

Amanda Chaperot Ph.D Affiliated Funds (1)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Digital Opportunities Fund Seventure Partners Venture - General Closed 2017

Amanda Chaperot Ph.D FAQs

  • Who is Amanda Chaperot Ph.D?

    Dr. Amanda Chaperot serves as Board Member at Vivet Therapeutics.

  • How much does Amanda Chaperot Ph.D typically invest?

    Amanda Chaperot Ph.D's median deal size is .

  • What is Amanda Chaperot Ph.D’s main position?

    Amanda Chaperot Ph.D’s primary position is Board Member.

  • How many active board seats does Amanda Chaperot Ph.D hold?

    Amanda Chaperot Ph.D holds 2 board seats including Cytoki and Vivet Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »